DMAG, a novel countermeasure for the treatment of thrombocytopenia

DMAG, a novel countermeasure for the treatment of thrombocytopenia

Abstract Background Thrombocytopenia is one of the most common hematological disease that can be life-threatening caused by bleeding complications. However, the treatment options for thrombocytopenia remain limited. Methods In this study, giemsa staining, phalloidin staining, immunofluorescence and...

Full description

Bibliographic Details
Main Authors: Jing Lin, Jing Zeng, Sha Liu, Xin Shen, Nan Jiang, Yue-Song Wu, Hong Li, Long Wang, Jian-Ming Wu
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Molecular Medicine
Subjects:
DMAG
Megakaryocytes
Platelets
Network pharmacology
Thrombocytopenia
Online Access:https://doi.org/10.1186/s10020-021-00404-1

Internet

https://doi.org/10.1186/s10020-021-00404-1

Similar Items